Refractory Equine Glandular Gastric Disease – Morbidity & Mortality Case-Discussions

Tue, 27 August, 2024 06:00 pm - 09:00 pm (Your Local Time Zone)



Contact Hours

3 Hours - RACE Accredited

Early Booking Deadline

Sun, 14 July, 2024

Registration Deadline

Fri, 02 August, 2024





Diagnostic Imaging

Internal Medicine – Endocrinology, Haematology, Infectious Diseases, Parasitology & Oncology


Pathology - Clinical & Gross

Toxicology & Pharmacology

Industry Partners


Veterinary Partners


Time: London 6PM / Paris 7PM / New York 1PM / Sydney 3:00AM (+1)


Gayle Hallowell   MA VetMB, PhD, Cert AVP (Veterinary Anaesthesia), DACVECC, DACVIM, PFHEA, FRCVS - IVC Evidensia, UK
Chris Sanchez   DVM, PhD - University of Florida, USA
Monica Venner   Dr.Med.Vet., PhD, DECEIM, Fachtierärztin für Pferde - Pferdeklinik Destedt GmbH, Germany


Michael Hewetson   BSc(Hons)Ag, BVSc., PhD, FHEA, DECEIM, MRCVS - Royal Veterinary College, UK



This interactive panel discussion brings together internationally recognised internal medicine specialists from Europe and the United States to discuss the challenges of treating Equine Glandular Gastric Disease (EGGD), and specifically, how best to manage horses that are refractory to treatment. The discussion will focus primarily on pharmacological management but will also touch on other management and feeding strategies that can be used to improve healing rates and mitigate against reoccurrence.

Whilst recognising the limitations surrounding availability of certain drug formulations in different countries, the panelists will debate what they consider to be ‘first line’ and ‘second line’ drugs for treatment of EGGD; how they use them to maximise efficacy; and how they would modify their approach in the case of a ‘non-responder’. The panelists will contribute a wealth of clinical experience and anecdote to the discussion but will be encouraged to justify their approaches based upon current evidence where available.

  • When do you consider a lesion healed?
  • How long should you wait before deciding a horse is a non-responder?
  • Is there any value (or science) in determining intragastric pH in non-responders? 
  • Should you biopsy lesions that are refractory to treatment? If so, how do you interpret the results?
  • What are the alternatives when acid suppression is not effective?  When do you reach for corticosteroids? 
  • Should competition horses be rested during treatment? Are there any other management strategies that might be effective? 
  • What is the role of the microbiome in horses with EGGD? Are antibiotics ever indicated? 
  • Are there any nutritional risk factors that could potentially delay or prevent healing?

Questions and comments from attending vets will be welcomed.

Dr. Sanchez is a professor and large animal internal medicine specialist and has been a member of the University of Florida faculty since 2003. Additionally, since January 2020, she has served as Interim Associate Dean for Clinical Services.

She received both her DVM in 1995 and PhD in 2003 from the University of Florida and has been a longtime member of the college’s Alumni Council. She completed her residency in large animal internal medicine in 1999 and obtained her board certification that same year.
In addition to her clinical and didactic teaching experience in large animal medicine, Dr. Sanchez has played a key role in various aspects of communication instruction to veterinary house officers, staff and students.

Her research focuses on three main areas: equine gastric ulcer syndrome, pain management in the horse and critical care of equine neonates. Her laboratory has evaluated the effectiveness of various drugs for the treatment of gastric ulcers in foals and adult horses and for pain management in adult horses.

Gayle graduated from the University of Cambridge and completed a rotating internship and then large animal internal medicine and critical care residency at the Royal Veterinary College in London. She then completed a PhD investigating aortic valve prolapse at the University of Nottingham. After 20 years in academia, she left in February 22 to become Director of veterinary Professional Development for IVC Evidensia. She still undertakes clinical work at Pool House Equine Hospital. She is an American Specialist in Large Animal Internal Medicine, American Specialist in Large Animal Emergency and Critical Care, EBVS Specialist in Veterinary Sports Medicine and Rehabilitation and is Associate Diplomate of the European College of Veterinary Diagnostic Imaging. She is also Editor-In-Chief for the Wiley Journal Veterinary Medicine and Science. The topics that she holds close to her heart which include large animal cardiology, gastroenterology and imaging (particularly ultrasonography).

Dr Michael Hewetson graduated from Onderstepoort, South Africa in 1999. He spent time in private equine practice in the UK before completing a residency in equine internal medicine at the University of Glasgow. He is a registered RCVS specialist in equine internal medicine and is a diplomate of the European College of equine internal medicine. He has a PhD in equine gastroduodenal permeability studies and has an active research interest in equine gastric ulcer syndrome. He currently works as a clinical educator at the Royal Veterinary College in London, where he an associate professor in equine internal medicine.

Qualified Vet

Online Panel Discussion

USD 85.00

Intern/Resident (Requires proof of status)

Online Panel Discussion

USD 65.00

Vet Nurse/Vet Tech (Requires proof of status)

Online Panel Discussion

USD 65.00

Veterinary Student (Requires proof of status)

Online Panel Discussion

USD 35.00

If the options you are looking for are unavailable, please contact us.

No tax will be added unless you are a UK taxpayer

Choose currency at checkout